Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07323472

Body Lateralization and Its Effects on Respiratory Drive, Ventilation, and Pulmonary Aeration in Critically Ill Patients

The goal of this quasi-experimental study is to investigate how different body positions, performed through Automatic Lateralization Therapy, affect respiratory drive, ventilation, and pulmonary aeration in critically ill adult patients under mechanical ventilation. The main questions this study aims to answer are:

* Does Automatic Lateralization Therapy, modify respiratory drive, as measured by P0.1, estimated Pmus, and sEMG of the diaphragm and parasternal muscles? * Is there an association between respiratory drive, ventilation, and pulmonary aeration measured by Electrical Impedance Tomography (EIT) in different body positions promoted by Automatic Lateralization Therapy ?

Does combining Automatic Lateralization Therapy, with Flow Bias improve physiological and functional outcomes compared to Automatic Lateralization Therapy, without Flow Bias?

Participants will:

* Be positioned in different lateralization strategies using Automatic Lateralization Therapy, while under mechanical ventilation; * Have respiratory parameters and ventilation images assessed by EIT and sEMG;

Participate only during their ICU stay, with no need for additional visits after discharge.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Intensive Care Units (ICUs) Critical Illness Disease Attributes Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hospital Geral Otávio de Freitas - Secretaria de Saúde de Pernambuco

Recife, Pernamu, 50670-901, Brazil

Location status: Recruiting

Location contact

Elaine Araújo de Souza, Specialist

SUB_INVESTIGATOR

Rômulo de Aquino Coelho Lins Direção do Hospital Geral Otávio de Freitas, MSc

CONTACT

[email protected]

+55 81 9 9486498

About this study

Detailed Description:

Critically ill patients under mechanical ventilation frequently develop respiratory complications due to immobility and altered pulmonary mechanics. Automatic Lateralization Therapy has emerged as a promising physiologic intervention to optimize ventilation and reduce respiratory dysfunction in this population. However, its effects on respiratory drive activation remain poorly understood.

Objective:

To evaluate the effects of body lateralization on respiratory drive activation, ventilation, and pulmonary aeration in mechanically ventilated critically ill patients.

Methods and Design:

This is a quasi-experimental, non-randomized physiological intervention study conducted in a controlled ICU environment, following the TREND 2025 Statement Checklist for transparent reporting of non-randomized evaluations. Automatic Lateralization Therapy will be applied with and without Flow Bias, using progressive body tilt angles (0°, 15°, and 30°). Positioning strategies will be personalized based on Electrical Impedance Tomography (EIT) findings to ensure optimal lung recruitment and safety.

Collected data will include:

Clinical and physiological parameters such as respiratory drive (P0.1, estimated Pmus),

Diaphragm and parasternal muscle activity via surface electromyography (sEMG),

Ventilatory mechanics and gas exchange,

Pulmonary aeration and regional ventilation distribution assessed by EIT,

Additional monitoring by lung ultrasound to confirm aeration patterns.

The investigator performing the physiological data analysis will be blinded to the intervention group to minimize bias. Cardiorespiratory safety (e.g., hemodynamic stability, oxygenation) and adverse events will be monitored throughout all procedures.

Expected Outcomes:

The study aims to provide insights into whether body lateralization through Automatic Lateralization Therapy, modulates respiratory drive and improves ventilation efficiency in critically ill patients. It is hypothesized that combining Automatic Lateralization Therapy, with Flow Bias will enhance pulmonary expansion, respiratory drive activation, and gas exchange efficiency compared to Automatic Lateralization Therapy, alone, while maintaining patient safety.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients of both sexes will be included;
  • Aged ≥ 18 years;
  • BMI 18-35 kg/m²;
  • Under invasive mechanical ventilation via orotracheal tube for ≥ 24 hours and expected to remain on mechanical ventilatory support for at least 48 hours;
  • Sedated (Richmond Agitation-Sedation Scale [RASS] -1 to -4);
  • Well adapted to protective ventilation strategies in VCV or PSV modes;
  • Presenting neural respiratory drive evidenced by a drop in Delta Pocc and/or the presence of assisted cycles;
  • Hemodynamically stable (mean arterial pressure between 60-120 mmHg, systolic arterial pressure between 90-180 mmHg, diastolic arterial pressure between 60-100 mmHg, and heart rate between 50-150 bpm) with or without vasoactive drugs at the time of data collection (> 0.1 to 0.3 mcg/kg/min);
  • Respiratory stability, no use of accessory muscles and target SpO₂ achieved;
  • No indication for nebulization or heated humidification at the time of collection;
  • Positive tolerance test for lateral decubitus positioning;
  • Chest circumference of 78-87.9 cm (XS), 88-99.9 cm (S), or 100-111.9 cm (M).

Exclusion criteria

  • Patients presenting medical restrictions to body repositioning, or to the use of EIT or sEMG;
  • Those in therapeutic failure;
  • Individuals with spinal cord injury, brain injury, or stroke with a history of functional loss and respiratory impairment prior to hospitalization;
  • Neurological diseases affecting respiratory myoelectric conduction;
  • History of postural deformities, diaphragmatic abnormalities, or colostomy bag;
  • Unstable fracture (lower or upper limbs in proximal regions or thorax);
  • Pleural effusion requiring drainage;
  • Presence of drains in the thoracic and/or abdominal regions;
  • Unstable intracranial pressure;
  • Pregnant patients;
  • Immediate postoperative period of orthopedic surgeries;
  • Use of mucolytics;
  • Open ventriculostomy for drainage;
  • Uncontrolled agitation;
  • Pacemaker or implantable cardioverter-defibrillator;
  • Pneumothorax;
  • Use of neuromuscular blockers;
  • Active tuberculosis;
  • Traction devices;
  • Active bleeding;
  • Suspected or confirmed pulmonary embolism without prior treatment within 24 hours;
  • Presence of a large mass in the right and/or left hemithorax;
  • History of cardiopulmonary arrest within the past 24 hours under neuroprotection;
  • In the total weaning phase from IMV and/or tracheostomy and/or enteral feeding tube and/or scheduled CT scan within the next 6 hours;
  • Intolerance to the TLA test (SpO₂ drop <92% or ≥20% from baseline, need for FiO₂ increase >50% or ≥20% from baseline, need for PEEP increase, or hemodynamic instability within the first 5 minutes of lateralization testing);
  • Those who refuse to provide consent, as determined by the legal representative.

Treatment and study plan

Automatic lateralization therapy

Other

During this phase of analysis and intervention related to lateral positioning, patients will be maintained on a Multicare bed (LINET) and subjected to personalized lateral positioning based on the morphofunctional pattern detected by electrical impedance tomography. This positioning will be performed using automatic lateralization therapy, programmed for unilateral or bilateral application, continuously alternating between angles of 0°, 15°, and 30°, maintained for 20 minutes at each position. The procedure will be conducted in two sequences, with the second sequence combined with the Flow Bias intervention. At each angle, data will be collected on hemodynamic monitoring, respiratory drive, respiratory mechanics, regional distribution of ventilation and aeration, and gas exchange.

Other names: Continuous lateral positioning, Automatic patient positioning, Continuous lateral rotation therapy, Lateral rotation therapy, Continuous rotational therapy, Kinetic bed therapy, Lateral change Positioning, Automated lateral rotation, Rotating bed, Automatic lateral therapy, Kinetic Therapy, Automated Lateral Rotation Therapy

Supine positioning

Other

During this analysis phase, patients will be positioned on a Multicare bed (LINET) in the dorsal decubitus position with the head of the bed elevated to 30°. Data will be collected on hemodynamic monitoring, respiratory drive, respiratory mechanics, degree of lung involvement, regional distribution of ventilation and aeration, and gas exchange.

Other names: Supine, Semi-recumbent position, Recumbent position, Dorsal decubitus, Conventional supine care

Primary outcomes

  1. Respiratory drive parameters: Surface electromyography (sEMG)

    Time frame: Unilateral: 140 minutes (2 hour 20 minutes) | Bilateral: 370 minutes (6 hour 10 minutes)

    The respiratory drive parameter will be assessed using surface electromyographic (sEMG) activity of the respiratory muscles, including the diaphragm and parasternal intercostals, expressed in microvolts (µV) (Silva Junior et al., 2023).

    Data are given in:

    • µV: Microvolts Measurements will be performed during the first and last 5 minutes of each body angulation. Unilateral: 140 minutes | Bilateral: 370 minutes. Following the sequence: Semi-seated 30°/20 minutes, Supine 0°/5 minutes, 15°/20 minutes, 30°/20 minutes, 15°/20 minutes, Supine 0°/5 minutes, and Semi-seated 30°/20 minutes, totaling 70 minutes per sequence plus 60 minutes of washout between sequences. This results in 140 minutes for patients undergoing Unilateral Lateralization Therapy and 370 minutes for patients undergoing Bilateral Lateralization Therapy.

  2. Respiratory drive parameter: P0.1 (airway occlusion pressure during the first 100 ms of the inspiratory effort)

    Time frame: Unilateral: 140 minutes (2 hour 20 minutes) | Bilateral: 370 minutes(6 hour 10 minutes)

    The respiratory drive parameter will be assessed by P0.1(airway occlusion pressure during the first 100ms of the inspiratory effort,cmH₂O).P0.1 is the drop in airway pressure within 100 ms after the onset of inspiration and is considered a reliable, fast, and feasible bedside marker.The following values are considered: Normal: 1.5-3.5 cmH₂O; Low: <1.0 cmH₂O(hypostimulated); High:>4.0 cmH₂O (hyperstimulated)(CHEN et al.,2023).

    Data are given in: cmH₂O: centimeters of water Measurements will be performed during the first and last 5 minutes of each body angulation. Unilateral: 140 minutes | Bilateral: 370 minutes. Following the sequence: Semi-seated 30°/20 minutes, Supine 0°/5 minutes, 15°/20 minutes, 30°/20 minutes, 15°/20 minutes, Supine 0°/5 minutes, and Semi-seated 30°/20 minutes, totaling 70 minutes per sequence plus 60 minutes of washout between sequences. This results in 140 minutes for patients undergoing Unilateral Lateralization Therapy and 370 minutes Bilateral.

  3. Respiratory drive parameters: Pmus (estimated inspiratory muscle pressure)

    Time frame: Unilateral: 140 minutes (2 hour 20 minutes) | Bilateral: 370 minutes (6 hour 10 minutes)

    The respiratory drive will be assessed using Pmus (estimated inspiratory muscle pressure). Pmus is derived from the airway pressure drop during a brief inspiratory occlusion and reflects inspiratory effort. Reference ranges: Pmus < 5 cmH₂O indicates over-assistance/low drive; Pmus ≤ 10 cmH₂O represents the diaphragmatic protection zone; Pmus > 13-15 cmH₂O indicates excessive effort (Dianti, Bertoni ;Goligher, 2020).

    Data are given in:

    •cmH₂O: centimeters of water

    Measurements will be performed during the first and last 5 minutes of each body angulation. Unilateral: 140 minutes | Bilateral: 370 minutes. Following the sequence: Semi-seated 30°/20 minutes, Supine 0°/5 minutes, 15°/20 minutes, 30°/20 minutes, 15°/20 minutes, Supine 0°/5 minutes, and Semi-seated 30°/20 minutes, totaling 70 minutes per sequence plus 60 minutes of washout between sequences. This results in 140 minutes for patients undergoing Unilateral Lateralization Therapy and 370 minutes for patients undergoing Bilateral

  4. Pulmonary ventilation: Ventilation Impedance Change (ΔZ)

    Time frame: Unilateral: 140 minutes (2 hour 20 minutes) | Bilateral: 370 minutes (6 hour 10 minutes)

    ΔZ will be quantified using electrical impedance tomography (EIT). ΔZ represents the sum of impedance changes of all pixels within a predefined region of interest (ROI), corresponding to regional tidal ventilation. ROIs will include right anterior, left anterior, right posterior, and left posterior lung regions, and will also be categorized as dependent or non-dependent lung areas. Data will be expressed in arbitrary units (a.u.).

    Measurements will be performed during the first and last 5 minutes of each body angulation. Unilateral: 140 minutes | Bilateral: 370 minutes. Following the sequence: Semi-seated 30°/20 minutes, Supine 0°/5 minutes, 15°/20 minutes, 30°/20 minutes, 15°/20 minutes, Supine 0°/5 minutes, and Semi-seated 30°/20 minutes, totaling 70 minutes per sequence plus 60 minutes of washout between sequences. This results in 140 minutes for patients undergoing Unilateral Lateralization Therapy and 370 minutes for patients undergoing Bilateral Lateralization Therapy.

  5. Pulmonary aeration: End-Expiratory Lung Impedance Change (ΔEELZ)

    Time frame: Unilateral: 140 minutes (2 hour 20 minutes) | Bilateral: 370 minutes (6 hour 10 minutes)

    ΔEELZ will be assessed using electrical impedance tomography (EIT). ΔEELZ corresponds to the aggregate end-expiratory impedance (sum of pixel values) within each ROI, representing changes in end-expiratory lung volume. ROIs will include right anterior, left anterior, right posterior, and left posterior lung regions, grouped as dependent or non-dependent areas. Data will be expressed in arbitrary units (a.u.).

    Measurements will be performed during the first and last 5 minutes of each body angulation. Unilateral: 140 minutes | Bilateral: 370 minutes. Following the sequence: Semi-seated 30°/20 minutes, Supine 0°/5 minutes, 15°/20 minutes, 30°/20 minutes, 15°/20 minutes, Supine 0°/5 minutes, and Semi-seated 30°/20 minutes, totaling 70 minutes per sequence plus 60 minutes of washout between sequences. This results in 140 minutes for patients undergoing Unilateral Lateralization Therapy and 370 minutes for patients undergoing Bilateral Lateralization Therapy.

Secondary outcomes

  1. Mechanical response associated with respiratory drive: Diaphragmatic excursion

    Time frame: Unilateral: 140 minutes (2 hour 20 minutes) | Bilateral: 370 minutes (6 hour 10 minutes)

    Diaphragmatic excursion will be assessed by ultrasonography using a convex transducer placed along the right mid-clavicular line, using the liver as an acoustic window. The procedure follows established ICU protocols and can be performed without ventilator disconnection. In this study, ventilation will remain connected, and diaphragmatic excursion will be quantified in millimeters (mm) (Santana et al., 2020).

    Data are given in: mm: Millimeters. Measurements will be performed during the first and last 5 minutes of each body angulation. Unilateral: 140 minutes | Bilateral: 370 minutes. Following the sequence: Semi-seated 30°/20 minutes, Supine 0°/5 minutes, 15°/20 minutes, 30°/20 minutes, 15°/20 minutes, Supine 0°/5 minutes, and Semi-seated 30°/20 minutes, totaling 70 minutes per sequence plus 60 minutes of washout between sequences. This results in 140 minutes for patients undergoing Unilateral Lateralization Therapy and 370 minutes for patients undergoing Bilateral.

  2. Mechanical response related to respiratory effort and lung stress: Dynamic transpulmonary driving pressure

    Time frame: Unilateral: 140 minutes (2 hour 20 minutes) | Bilateral: 370 minutes (6 hour 10 minutes)

    Dynamic transpulmonary driving pressure (cmH₂O) will assess the mechanical response to respiratory effort and lung stress. It is derived from the same expiratory occlusion maneuver used for Pmus, applying a correction formula to isolate lung distension. This provides a non-invasive measure of dynamic lung stress during ventilation. Recent studies have targeted values between 15 and 20 cmH₂O (Dianti et al., 2022).

    Data are given in: cmH₂O: centimeters of water

    Measurements will be performed during the first and last 5 minutes of each body angulation. Unilateral: 140 minutes | Bilateral: 370 minutes. Following the sequence: Semi-seated 30°/20 minutes, Supine 0°/5 minutes, 15°/20 minutes, 30°/20 minutes, 15°/20 minutes, Supine 0°/5 minutes, and Semi-seated 30°/20 minutes, totaling 70 minutes per sequence plus 60 minutes of washout between sequences. This results in 140 minutes for patients undergoing Unilateral Lateralization Therapy and 370 minutes for patients undergoing Bilateral.

  3. Driving Pressure (cmH₂O)

    Time frame: Unilateral: 140 minutes (2 hour 20 minutes) | Bilateral: 370 minutes (6 hour 10 minutes)

    Driving pressure will be assessed using ventilator-derived parameters during mechanical ventilation to estimate lung stress under different body angulations and lateralization strategies. Driving pressure will be calculated as the difference between plateau pressure (Pplat) and positive end-expiratory pressure (PEEP), according to the formula: Driving Pressure = Pplat - PEEP.

    Data will be expressed in: cmH₂O (centimeters of water). Measurements will be performed during the first and last 5 minutes of each body angulation. Unilateral: 140 minutes | Bilateral: 370 minutes. Following the sequence: Semi-seated 30°/20 minutes, Supine 0°/5 minutes, 15°/20 minutes, 30°/20 minutes, 15°/20 minutes, Supine 0°/5 minutes, and Semi-seated 30°/20 minutes, totaling 70 minutes per sequence plus 60 minutes of washout between sequences. This results in 140 minutes for patients undergoing Unilateral Lateralization Therapy and 370 minutes for patients undergoing Bilateral Lateralization Therapy.

  4. Respiratory System Compliance (mL/cmH₂O)

    Time frame: Unilateral: 140 minutes (2 hours and 20 minutes) Bilateral: 370 minutes (6 hours and 10 minutes)

    Respiratory system compliance will be evaluated using ventilator-derived parameters to assess lung distensibility during different body angulations and lateralization strategies under mechanical ventilation.

    Respiratory system compliance will be calculated as the ratio between tidal volume (VT) and driving pressure, according to the formula:

    Compliance = VT/ (plateau press - PEEP).

    Data will be expressed in: cmH₂O (centimeters of water). Measurements will be performed during the first and last 5 minutes of each body angulation. Unilateral: 140 minutes | Bilateral: 370 minutes. Following the sequence: Semi-seated 30°/20 minutes, Supine 0°/5 minutes, 15°/20 minutes, 30°/20 minutes, 15°/20 minutes, Supine 0°/5 minutes, and Semi-seated 30°/20 minutes, totaling 70 minutes per sequence plus 60 minutes of washout between sequences. This results in 140 minutes for patients undergoing Unilateral Lateralization Therapy and 370 minutes for patients undergoing Bilateral Lateralization Therapy.

  5. Airway Resistance (cmH₂O/L/s)

    Time frame: Unilateral: 140 minutes (2 hours and 20 minutes) Bilateral: 370 minutes (6 hours and 10 minutes)

    Airway resistance will be measured using ventilator-derived parameters to evaluate airflow resistance during mechanical ventilation across different body angulations and lateralization strategies.

    Calculated as the difference between peak inspiratory pressure (Ppeak) and plateau pressure (Pplat) divided by inspiratory flow, according to the formula:

    Airway Resistance = (Ppeak - Pplat) / Inspiratory Flow

    Data will be expressed in: cmH₂O (centimeters of water). Measurements will be performed during the first and last 5 minutes of each body angulation. Unilateral: 140 minutes | Bilateral: 370 minutes. Following the sequence: Semi-seated 30°/20 minutes, Supine 0°/5 minutes, 15°/20 minutes, 30°/20 minutes, 15°/20 minutes, Supine 0°/5 minutes, and Semi-seated 30°/20 minutes, totaling 70 minutes per sequence plus 60 minutes of washout between sequences. This results in 140 minutes for patients undergoing Unilateral Lateralization Therapy and 370 minutes for patients undergoing Bilateral

  6. Arterial pH

    Time frame: Baseline; immediately after Sequence 1; immediately after Sequence 2. Unit: pH units.

    Arterial pH measured from arterial blood gas (ABG) analysis at predefined time points: baseline (prior to the first intervention), immediately after completion of Sequence 1, and immediately after completion of Sequence 2.

    Unit: pH units.

  7. Partial pressure of oxygen (PaO₂)

    Time frame: Baseline; immediately after Sequence 1; immediately after Sequence 2.

    Arterial PaO₂ measured via arterial blood gas at baseline, immediately after Sequence 1, and immediately after Sequence 2. Values obtained from arterial blood samples analyzed by standard blood gas analyzer.

    Unit: mmHg.

  8. Partial pressure of carbon dioxide (PaCO₂)

    Time frame: Baseline; immediately after Sequence 1; immediately after Sequence 2.

    Arterial PaCO₂ measured via arterial blood gas at baseline, immediately after Sequence 1, and immediately after Sequence 2.

    Unit: mmHg.

  9. Bicarbonate (HCO₃-)

    Time frame: Baseline; immediately after Sequence 1; immediately after Sequence 2.

    Arterial bicarbonate (HCO₃-) concentration obtained from arterial blood gas analysis at baseline, immediately after Sequence 1, and immediately after Sequence 2.

    Unit: mEq/L.

  10. Lactate

    Time frame: Baseline; immediately after Sequence 1; immediately after Sequence 2.

    Arterial lactate concentration obtained from arterial blood gas or arterial blood sample at baseline, immediately after Sequence 1, and immediately after Sequence 2.

    Unit: mmol/L.

  11. Base Excess (BE)

    Time frame: Baseline; immediately after Sequence 1; immediately after Sequence 2.

    Base excess determined from arterial blood gas analysis at baseline, immediately after Sequence 1, and immediately after Sequence 2.

    Unit: mEq/L.

  12. PaO₂/FiO₂ ratio

    Time frame: Baseline; immediately after Sequence 1; immediately after Sequence 2.

    PaO₂/FiO₂ ratio calculated from arterial PaO₂ and the fraction of inspired oxygen (FiO₂) at baseline, immediately after Sequence 1, and immediately after Sequence 2. FiO₂ will be recorded at the time of each arterial blood gas sampling.

    Ratio (unitless).

  13. Pulmonary Severity - LUS Score (Lung Ultrasound Score)

    Time frame: Baseline, immediately after Sequence 1, and immediately after Sequence 2.

    Pulmonary severity will be assessed using lung ultrasound (LUS), quantified by the Lung Ultrasound Score (LUS Score). Assessments will occur at three predefined time points: baseline (prior to the first intervention), immediately after the completion of Sequence 1, and immediately after the completion of Sequence 2.

    Pulmonary aeration will be classified according to standardized LUS Score criteria Mongodi, Silvia et al. Anesthesiology, 2021.

    Score 0: Normal lung pattern; up to two isolated B-lines. Score 1: Up to four B-lines, indicating mild loss of aeration. Score 2: More than four B-lines or confluent B-lines, indicating moderate loss of aeration.

    Score 3: Consolidations with coarse artifacts and pleural irregularities, indicating severe loss of aeration.

    Outcome Units: Ordinal scale (0 to 3 per region) and total summed score.

  14. Hemodynamic Instability Events

    Time frame: At any time during the intervention and immediately after completion.

    Number of hemodynamic instability episodes defined by sustained Mean Arterial Pressure (MAP) < 60 mmHg or > 120 mmHg, each lasting more than 10 minutes, recorded throughout the intervention period. Unit: Number of events

  15. Psychomotor Agitation - Richmond Agitation-Sedation Scale (RASS Score)

    Time frame: Unilateral: 140 minutes (2 hour 20 minutes) | Bilateral: 370 min (6 hour 10 minutes)

    Psychomotor agitation or sedation will be assessed using the Richmond Agitation-Sedation Scale (RASS) during each predefined body position and angulation throughout the therapy sequence.

    The RASS score ranges from -5 (unarousable) to +4 (combative), with higher positive scores indicating greater agitation and more negative scores indicating deeper levels of sedation.

    During each body position and angulation within the intervention sequence, assessed at the end of each positioning period, including:

    Semi-seated 30° (20 minutes) Supine 0° (5 minutes) Lateralization 15° (20 minutes) Lateralization 30° (20 minutes) Lateralization 15° (20 minutes) Supine 0° (5 minutes) Semi-seated 30° (20 minutes), for a total of 70 minutes per sequence, with a 60-minute washout period between sequences.

  16. Oxygenation and Hypoxemia Events (SpO₂ Monitoring + Hypoxemia Criteria)

    Time frame: Continuous monitoring; events recorded at any time during the intervention.

    Continuous monitoring of peripheral oxygen saturation (SpO₂) during each therapy session.

    Any episode meeting one or more of the following hypoxemia criteria will be recorded:

    • SpO₂ < 92%, or > 20% decrease from baseline;
    • Need to increase FiO₂ > 50% or > 20% above baseline;
    • Need to increase PEEP;
    • Associated hemodynamic instability (including changes in PAM according to predefined limits).

    All events will be documented throughout the intervention. Unit: Number of events.

  17. Unplanned Removal of Devices

    Time frame: During the intervention.

    Occurrence of unplanned removal of tubes or catheters during therapy (e.g., endotracheal tube, feeding tube, urinary catheter). Unit: Number of events.

  18. Serious Adverse Events

    Time frame: During the intervention.

    Occurrence of pneumothorax, cardiopulmonary arrest, or any event requiring emergency interruption or modification of therapy. Unit: Number of events.

Other outcomes

  1. Clinical Severity - SAPS 3 (Baseline)

    Time frame: Baseline (pre-intervention).

    Baseline clinical severity will be assessed using the Simplified Acute Physiology Score 3 (SAPS 3). This score provides a standardized measure of acute illness severity based on physiological, laboratory, and clinical variables collected within the first hours of ICU admission. SAPS 3 generates a total score typically ranging from 0 to 217, with higher scores indicating greater severity and higher predicted mortality risk (Salluh; Soares, 2014). The score will be recorded once before any intervention and used solely for sample characterization and stratification.

Study contacts

Contact information is provided by the study sponsor or research team.

Emanuel Fernandes Ferreira da Silva Júnior, MSc

CONTACT

[email protected]

+ 55 81 99703-9934

Shirley Lima Campos, PhD

CONTACT

[email protected]

+5581999413087

Sponsors and collaborators

Lead sponsor

University of Pernambuco

Other

Collaborators

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Amparo à Ciência e Tecnologia de Pernambuco
  • Universidade Federal de Pernambuco

Registry information

Official study title

Analysis of Respiratory Drive Activation, Ventilation, and Pulmonary Aeration Resulting From Body Lateralization in Critically Ill Patients Under Mechanical Ventilation

Acronym: LATLUNG

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jan 7, 2026
Registry last updated
Jan 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.